← FDA Drug Approvals (Drugs@FDA)

ESOMEPRAZOLE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2020-04-01

Drug application

FDA Application #
ANDA203349
Application type
Abbreviated New Drug Application (Generic)
Brand name
ESOMEPRAZOLE SODIUM
Generic name
ESOMEPRAZOLE SODIUM
Active ingredients
ESOMEPRAZOLE SODIUM
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
Gland Pharma Limited
First approval
2020-04-01

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown